GLAUCOMA 360

The Pressure's On: An Inside Look at the Glaucoma Treatment Market - Kristin H. Ingenito, MBA, Vice President, Director of Ophthalmics, Market Scope.

The 11th Annual Glaucoma 360 New Horizons Forum took place on February 11, 2022 at the Grand Hyatt San Francisco. Presented by Glaucoma Research Foundation.

Diagnostics: Getting Smarter, Smaller and Virtually Leaving Your Practice -
Moderators:
Sean Ianchulev, MD, MPH
Professor of Ophthalmology, Director of Innovation and Technology, New York
Eye and Ear of Mount Sinai, Icahn School of Medicine; CEO, Eyenovia, Inc.
Joel S. Schuman, MD, FACS
Elaine Langone Professor of Ophthalmology & Vice Chair for Ophthalmology
Research, Professor of Neuroscience and Physiology, NYU Langone Health, NYU
Grossman School of Medicine; Professor of Biomedical Engineering and Electrical
& Computer Engineering, NYU Tandon School of Engineering; Professor of Neural
Science, NYU College of Arts and Sciences
Speakers:
AEYE Health, Zack Dvey-Aharon, PhD, CEO and Co-Founder
Eyenuk Inc., Kaushal Solanki, PhD, CEO and Founder
Hao F. Zhang, PhD, Professor of Biomedical Engineering, Northwestern University
Heru, Mary Durbin, PhD, Chief Scientific Officer
FDA, Malvina Eydelman, MD, Director of the Office of Health Technology,
Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices
Ophthalmic Sciences, Ariel Weinstein, MSc, EMT-P, Chief Executive Officer
Audience Q&A

The 11th Annual Glaucoma 360 New Horizons Forum took place on February 11, 2022 at the Grand Hyatt San Francisco. Presented by Glaucoma Research Foundation.

Remote Patient Management: Are We Ready?
Moderators:
Lama Al-Aswad, MD, MPH
Vice Chair of Innovations, Langone Department of Ophthalmology; Professor of
Ophthalmology and Director of Tele-Ophthalmology, Artificial Intelligence and
Innovations, Director of the Ophthalmology Innovation Fellowship, NYU Langone
Eye Center
Oluwatosin “Tosin” Smith, MD
Attending Physician and Surgeon, Glaucoma Associates of Texas; Associate
Professor of Ophthalmology, Department of Ophthalmology, University of Texas
Southwestern Medical School.
Panelists:
Malvina Eydelman, MD, Director of the Office of Health Technology, Ophthalmic,
Anesthesia, Respiratory, ENT and Dental Devices, FDA
Ronald L. Fellman, MD, Glaucoma Specialist, Ophthalmologist, Glaucoma
Associates of Texas and The Cure Glaucoma Foundation
Jonathan S. Myers, MD, Chief, Glaucoma Service, Wills Eye Hospital; Professor,
Sidney Kimmel Medical College, Thomas Jefferson University
Speakers:
Aenor J. Sawyer, MD, MS, Director of UCSF Skeletal Health Service; Director of
UC Space Health, Department of Orthopaedic Surgery, UCSF; Co-Director of UCSF
Center for Advanced 3D + Technologies
Seanna Grob, MD, MS, Assistant Professor, Depart of Ophthalmology, University
of California, San Francisco
Implandata Ophthalmic Products, Max Ostermeier, CEO & Founder
Microsoft, Pam Nesbitt, MSc, Global Healthcare Lead, CSE
PeriVision, Patrick Kessel, Chief Executive Officer and Co-founder
Twenty Twenty Therapeutics, Christian Gutierrez, PhD, Head of Digital
Therapeutics and Director of Business Development
Audience Q&A

The 11th Annual Glaucoma 360 New Horizons Forum took place on February 11, 2022 at the Grand Hyatt San Francisco. Presented by Glaucoma Research Foundation.

Forum Summation —
Jonathan S. Myers, MD
Chief, Glaucoma Service, Wills Eye Hospital; Professor, Sidney Kimmel Medical
College, Thomas Jefferson University
Ann Quan, MD
Glaucoma and Cataract Specialist, Scripps Clinic; Voluntary Assistant
Professor, Bascom Palmer Eye Institute

The 11th Annual Glaucoma 360 New Horizons Forum took place on February 11, 2022 at the Grand Hyatt San Francisco. Presented by Glaucoma Research Foundation.

Expanding Beyond the Horizon with Devices in Glaucoma -
Moderators:
Shan Lin, MD, Ophthalmologist, Glaucoma Center of San Francisco
Barbara Wirostko, MD, FARVO
Chief Medical Officer and Co-Founder, Qlaris Bio Inc.; Adjunct Professor,
Department of Ophthalmology, Moran Eye Center and Department of Biomedical
Engineering, University of Utah
Presenting Companies:
Ace Vision, AnnMarie Hipsley, DPT, PhD, Founder and CEO
Iridex, David Bruce, President and Chief Executive Officer
MicroOptx, Chris Pulling, Chief Executive Officer
OcuFLOW, Theresa Kramer, MD, MBA, President, Founder, CEO and CMO
Robert Weinreb, MD, Chair & Distinguished Professor of Ophthalmology,
Director of the Shiley Eye Institute, Distinguished Professor of Bioengineering,
University of California, San Diego
ViaLase, Tibor Juhasz, Chief Executive Officer
W. L. Gore & Associates, Kevin Savory, PhD, Product Specialist
Audience Q&A

The 11th Annual Glaucoma 360 New Horizons Forum took place on February 11, 2022 at the Grand Hyatt San Francisco. Presented by Glaucoma Research Foundation.

Financing Trends in Biotechnology and Ophthalmology -
Moderator: Emmett Cunningham, Jr., MD, PhD, MPH
Senior Managing Director, Blackstone Life Sciences
Panelists:
Wende Hutton, General Partner, Canaan
Judith Li, Partner, Lilly Asia Ventures
Jonathan Norris, Managing Director, Healthcare Practice, Silicon Valley Bank
Robert Rothman, MD, Co-Founder and Managing Member, InFocus Capital
Partners

The 11th Annual Glaucoma 360 New Horizons Forum took place on February 11, 2022 at the Grand Hyatt San Francisco. Presented by Glaucoma Research Foundation.